Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Press release announces Guardian Pharmacy Services’ financial results for quarter ended September 30, 2026.
Guardian Pharmacy Services, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release announces Guardian Pharmacy Services’ financial results for quarter ended September 30, 2026
- Exhibit 99.1 contains the detailed earnings figures and management commentary
- Investors should review the exhibit for revenue, profitability, cash flow and outlook implications
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $371.1M, down 2% YoY despite residents served increasing 7% to approximately 218,000, reflecting IRA pricing pressure
- Net income $19.1M versus $9.6M, while Adjusted EBITDA rose 24% to $33.9M and margin expanded to 9.1% from 7.2%
- Nine-month operating cash flow $79.5M and cash $119.7M, with no long-term credit-facility debt, supporting acquisitions and greenfield expansion
- FY2026 guidance raised: revenue $1.44B-$1.46B and Adjusted EBITDA $136M-$138M, excluding future acquisitions
- Acquisition pipeline expanded through Wellness Concepts, Nautilus assets, Van’s Institutional Pharmacy and Sioux City operations, increasing regional scale and infrastructure utilization
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Guardian Pharmacy Services, Inc. 8-K filings
Get the next GRDN 8-K as it lands
Follow GRDN for push alerts, or ask the research agent what this filing means.